Literature DB >> 8858523

Electric shock-like sensations in 42 cancer patients: clinical characteristics and distinct etiologies.

A Lossos1, T Siegal.   

Abstract

We retrospectively evaluated 42 consecutive cancer patients manifesting electric shock-like sensations. Fourty three percent presented with Lhermitte's sign (LS), 24% with the previously described outstretching ir. abduction maneuver (OAM) of the arms, and 33% had both phenomena. Twenty nine patients had underlying polyneuropathy related to cisplatin-based chemotherapy in 27 and to thiamine deficiency in 2. Thirtreen patients had myelopathy which was induced by radiotherapy in 11. Patients with polyneuropathy manifested both LS and OAM, while patients with myelopathy more often presented with LS. Neurologic signs suggestive of spinal cord involvement were present in 3 patients with polyneuropathy and in 7 of 11 irradiated patients. MRI disclosed cervical spinal cord swelling in 3 patients with LS. Prolonged cervical latencies on SSER were noted in 5 of 15 patients. All had LS and 3 also had OAM associated with abnormal latencies in the brachial plexi. We conclude that LS and OAM are positive sensory manifestations of increased mechanosensitivity of the damaged central or peripheral sensory axons in the cervico-brachial area. In cancer patients, these phenomena largely manifest treatment-induced myelopathy or polyneuropathy. Auxillary studies help to confirm diagnosis and to depict the uncommon but treatable causes.

Entities:  

Mesh:

Year:  1996        PMID: 8858523     DOI: 10.1007/bf00182141

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  Invited review: permanent radiation myelopathy.

Authors:  T E Schultheiss; L C Stephens
Journal:  Br J Radiol       Date:  1992-09       Impact factor: 3.039

Review 2.  On the significance of Lhermitte's sign in oncology.

Authors:  V Ventafridda; A Caraceni; C Martini; A Sbanotto; F De Conno
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

3.  Survival and complications of radiotherapy following involved and extended field therapy of Hodgkin's disease, stages I and II. A collaborative study.

Authors:  J J Nickson; L M Fuller; G B Hutchison; H S Kaplan; D Karnofsky; B J Lee; M V Peters
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

4.  Polyneuropathy induced by cisplatin.

Authors:  B W Ongerboer de Visser; G Tiessens
Journal:  Prog Exp Tumor Res       Date:  1985

5.  Transient radiation myelopathy (Lhermitte's sign) in patients with Hodgkin's disease treated by mantle irradiation.

Authors:  J A Word; U P Kalokhe; B S Aron; H R Elson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-12       Impact factor: 7.038

6.  Development of Lhermitte's sign after bone marrow transplantation.

Authors:  P Y Wen; K L Blanchard; C C Block; J S Loeffler; D G Davis; L A Lacroix; J H Antin
Journal:  Cancer       Date:  1992-05-01       Impact factor: 6.860

7.  Neurotoxic effects of cisplatin therapy.

Authors:  T J Walsh; A W Clark; I M Parhad; W R Green
Journal:  Arch Neurol       Date:  1982-11

8.  The tolerance of primate spinal cord to re-irradiation.

Authors:  K K Ang; R E Price; L C Stephens; G L Jiang; Y Feng; T E Schultheiss; L J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-02-15       Impact factor: 7.038

9.  Ectopic sensory discharges and paresthesiae in patients with disorders of peripheral nerves, dorsal roots and dorsal columns.

Authors:  Magnus Nordin; Bo Nyström; Urban Wallin; Karl-Erik Hagbarth
Journal:  Pain       Date:  1984-11       Impact factor: 6.961

10.  Lhermitte's sign: incidence and treatment variables influencing risk after irradiation of the cervical spinal cord.

Authors:  D A Fein; R B Marcus; J T Parsons; W M Mendenhall; R R Million
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-12-01       Impact factor: 7.038

View more
  3 in total

Review 1.  A review on radiogenic Lhermitte's sign.

Authors:  Olga Esik; Tibor Csere; Klára Stefanits; Zsolt Lengyel; Géza Sáfrány; Katalin Vönöczky; Erzsébet Lengyel; Csaba Nemeskéri; Imre Repa; Lajos Trón
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

Review 2.  Toxicity of treatment for neoplastic meningitis.

Authors:  Tali Siegal
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

3.  PET identifies transitional metabolic change in the spinal cord following a subthreshold dose of irradiation.

Authors:  Olga Esik; Miklós Emri; Szabolcs Szakáll; Hans Herzog; Géza Sáfrány; Erzsébet Lengyel; András Boér; Gabriella Liszkay; Lajos Trón; Zsolt Lengyel; Imre Repa
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.